Add BrightSurf on Google Email

Research by UVA faculty member could help prevent organ transplant rejection

Researchers have made breakthroughs in creating nanoparticles that can modify the immune system to accept transplanted organs without compromising it. This new approach has potential implications for treating diabetes, cell therapy, and autoimmune disorders, offering hope for patients who currently face rejection.

SourceUniversity of Virginia School of Engineering and Applied Science·JournalProceedings of the National Academy of Sciences·DateOct 4, 2024

Immunotherapy for gum disease? Study in mice shows promise

A new study published in PNAS suggests that delivering microparticles containing CCL2 directly to the gums can inhibit bone loss and speed up bone repair in a mouse model of periodontal disease. The therapy modulates the immune response, shifting macrophages from inflammatory M1 type to anti-inflammatory M2 type.

SourceUniversity of Pittsburgh·JournalProceedings of the National Academy of Sciences·DateSep 30, 2024

Research findings offer a unique opportunity for early diagnosis and therapeutic intervention for rheumatoid arthritis

Researchers propose a better understanding of inflammation in rheumatoid arthritis, identifying an early pathogenic macrophage cell/gene signature that shapes the inflammatory environment. This discovery offers a unique opportunity for early diagnosis and therapeutic intervention, potentially leading to improved patient outcomes.

SourceTrinity College Dublin·JournalScience Advances·TypeMeta-analysis·DateSep 27, 2024

Inflammatory cells in tumor microenvironment promote the transformation of prostate cancer cells into treatment-resistant cells

A new study by the University of Eastern Finland found that pro-inflammatory macrophages can transform prostate cancer cells into stem-like cells, making them resistant to treatment. The study reveals that these immune cells secrete factors that increase the expression of stem cell markers in prostate cancer cells.

SourceUniversity of Eastern Finland·JournalOncoImmunology·TypeExperimental study·DateSep 20, 2024

Low oxygen levels in tumors could enhance some of the body’s immune responses against cancer

A recent study by Dr. Esteban Ballestar's group identifies an immune cell population that is more effective in responding against cancer cells under hypoxia. Macrophages undergo changes that enhance their ability to trigger an immune response, leading to better patient outcomes in bladder and ovarian cancers.

SourceJosep Carreras Leukaemia Research Institute·JournalScience Advances·TypeExperimental study·DateSep 19, 2024

Multi-omics strategy reveals that Cordyceps Sinensis ameliorates sepsis-associated acute kidney injury via reprogramming of mitochondrial energy metabolism and macrophage polarization

Researchers investigated the potential pharmacological action of Cordyceps Sinensis against sepsis-associated acute kidney injury. CS treatment improved renal function, suppressed inflammatory cytokine expression, and promoted mitochondrial complex activity.

SourceCompuscript Ltd·JournalActa Materia Medica·DateAug 7, 2024

New hope for prostate cancer: new form of immunotherapy could prevent resistance to hormone therapy

Researchers from the University of Sheffield have developed a new form of immunotherapy using nanoparticles that delays the onset of resistance to hormone therapy in prostate cancer. This innovative approach stimulates immune cells called T cells to attack cancer cells, marking a significant breakthrough in treating prostate cancer.

SourceUniversity of Sheffield·JournalBMJ·TypeExperimental study·DateAug 5, 2024

Obesity-cancer connection discovery suggests strategies for improving immunotherapy

A Vanderbilt University Medical Center-led research team discovered a connection between obesity and cancer, revealing that macrophages play an unexpected role in the complicated connection. Obesity increases macrophage frequency in tumors and induces PD-1 expression, which can contribute to both increased cancer risk and enhanced resp...

SourceVanderbilt University Medical Center·JournalNature·TypeExperimental study·DateJun 12, 2024

Understanding a broken heart

A new study reveals that heart failure leaves a 'stress memory' in hematopoietic stem cells, which can lead to recurrent heart failure and other health issues. The researchers propose improving TGF-β levels as a new avenue for treating recurrent heart failure.

SourceUniversity of Tokyo·JournalScience Immunology·TypeRandomized controlled/clinical trial·DateMay 24, 2024

Drug helps reprogram macrophage immune cells, suppress prostate and bladder tumor growth

A novel therapy has been developed to reprogram macrophage immune cells, shifting their balance toward antitumor activity. The treatment, JHU083, blocks the use of glutamine in tumors, reducing growth and triggering cell death. It also boosts immune-activating macrophages, recruiting tumor-killing T-cells and natural killer cells.

SourceJohns Hopkins Medicine·JournalCancer Immunology Research·DateMay 21, 2024

POSTECH and ImmunoBiome team make strides in microbiome-based cancer therapies by iron deprivation at the tumor microenvironment

A team of POSTECH and ImmunoBiome has discovered a dietary-derived bacterial strain, IMB001, that induces nutritional immunity and boosts anti-tumor responses. The strain works by skewing tumor-infiltrating macrophages toward an inflammatory phenotype, leading to increased cell death of rapidly multiplying tumor cells.

Chinese Medical Journal review explores cell-based immunotherapies for sepsis

Researchers review cell-based therapies for comprehensive sepsis management, highlighting the potential of mesenchymal stem cells and innate immune cells like macrophages. The review also emphasizes the need for further studies on optimal dosage, administration routes, and storage methods to maximize efficacy and safety.

SourceCactus Communications·JournalChinese Medical Journal·TypeLiterature review·DateMay 16, 2024

Mesenchymal stem cells alleviate acute liver failure through regulating hepatocyte apoptosis and macrophage polarization

Human umbilical cord mesenchymal stem cells (hUC-MSCs) have been shown to alleviate acute liver failure by inhibiting hepatocyte apoptosis and regulating macrophage polarization. This study suggests that hUC-MSC-based cell therapy may serve as an alternative option for patients with liver failure.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateMay 15, 2024

Identifying a new liver defender: The role of resident macrophages

Researchers at Osaka University discovered that certain 'sentinel macrophages' near the liver's entrance protect it against intestinal bacteria and related substances. Isoallo-lithocholic acid triggers their activation, highlighting a potential target for preventing liver inflammation and metabolic dysfunction-associated steatohepatitis.

SourceOsaka University·JournalNature·TypeImaging analysis·DateApr 25, 2024

Understanding the cellular mechanisms of obesity-induced inflammation and metabolic dysfunction

The study reveals that TM4SF19 protein inhibits a pump in lysosomes, impeding macrophage clearance of dead cells. Macrophages lacking TM4SF19 demonstrate enhanced efficacy in clearing dead adipocytes, reducing weight gain and metabolic dysfunction. The findings may open new avenues for treating obesity and related metabolic disorders.

SourcePohang University of Science & Technology (POSTECH)·JournalNature Communications·DateApr 24, 2024

Opto-RANK: A light switch for osteoclasts

Scientists from Tokyo Medical and Dental University have created Opto-RANK, a light-activated form of RANK that can induce osteoclast differentiation. The treatment approach uses blue light activation to stimulate local bone resorption, making it a promising tool for treating abnormal calcification diseases and orthodontic issues.

SourceTokyo Medical and Dental University·JournalScientific Reports·DateMar 21, 2024

DNA attached to nanoparticles contributes to lupus symptoms

A new study by Duke University researchers provides fundamental insights into autoimmune diseases, including systemic lupus erythematosus. They developed a system to test how DNA attached to nanoparticles interact with the immune system, revealing that larger nanoparticles provide more protection for DNA.

SourceDuke University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 21, 2024

Progress in developing specific immunotherapies for type 1 diabetes

Researchers have developed a novel immunotheraphy targeting macrophages to induce tolerance in type 1 diabetes, demonstrating its potential as a curative treatment. The therapy also shows promise for other autoimmune diseases, with results suggesting no impact on the immune system's ability to capture and process liposomes.

SourceGermans Trias i Pujol Research Institute·JournalJournal of Autoimmunity·TypeExperimental study·DateMar 18, 2024

Revolutionary genomic study sheds light on immune microenvironment in transplanted pediatric hearts

A team of researchers from Texas Heart Institute and Baylor College of Medicine have made a significant discovery about the underlying molecular cell states within transplanted pediatric hearts. They found that donor-derived tissue-resident macrophages are crucial for graft acceptance, but their loss leads to allograft failure.

SourceTexas Heart Institute·JournalCirculation·TypeExperimental study·DateFeb 12, 2024

Disrupted cellular function behind type 2 diabetes in obesity

A recent study published in PNAS suggests that impaired macrophage function plays a key role in the development of type 2 diabetes in obese individuals. The research found that collagen breakdown is handled by macrophages, which become deactivated in obesity and insulin resistance, leading to the accumulation of collagen fragments.

SourceUniversity of Gothenburg·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateFeb 1, 2024

New insights into what helps Salmonella cause infections

Researchers have discovered how the TamAB system helps Salmonella survive under harsh conditions inside macrophages. The study found that TamAB creates favorable conditions for the Bam complex to work, but the exact mechanism is unclear. Understanding this process could help in developing treatments for Salmonella infections.

SourceCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign·JournalJournal of Bacteriology·TypeExperimental study·DateJan 11, 2024

Asbestos: the size and shape of inhaled nanofibers could be exclusively responsible for the development of pulmonary fibrosis

Research reveals that inhaling asbestos or similar nanofibers can lead to pulmonary fibrosis due to their inability to be fully encapsulated by macrophages. The study found that fibers over 15 microns in length cause leaked secretions harmful to alveolar walls, leading to repeated pulmonary lesions and potential fibroma development.

SourceCNRS·JournalNature Nanotechnology·DateJan 5, 2024

Using the body’s own cells to treat traumatic brain injury

Researchers at the Wyss Institute have created a new treatment for traumatic brain injury (TBI) that leverages macrophages to deliver localized anti-inflammatory treatment. The approach reduced lesion size by 56% and significantly decreased local inflammation levels in pigs, offering a promising new direction for TBI treatment.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalPNAS Nexus·TypeExperimental study·DateJan 3, 2024

Shining a light on the hidden damage of mild brain injuries

Researchers created a new brain imaging method that allows diagnosis of mild traumatic brain injuries (mTBI) even when existing imaging techniques don't show structural abnormalities. The technique uses immune cells to carry imaging agents into the brain, increasing correctly diagnosed mTBI cases and improving patient care.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalScience Translational Medicine·TypeExperimental study·DateJan 3, 2024